Iomeron Injection, Solution
NDC Package 76381-930-06

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Iomeron (iomeprol injection) injection is classified as a

administered via intravascular route. This formulation utilizes a injection, solution delivery system. Marketed by Bipso Gmbh, this product is identified by NDC 76381-930.

Identification & Billing

NDC Package Code
76381-930-06
Package Description
6 BOTTLE, GLASS in 1 BOX / 500 mL in 1 BOTTLE, GLASS
Product Code
76381-930
11-Digit Billing Format
76381093006

Clinical Specifications

Proprietary Name
Iomeron
Non-Proprietary Name
Iomeprol Injection
Substance Name
Iomeprol
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
Intravascular - Administration within a vessel or vessels.
Active Ingredient(s)
IOMEPROL 612 mg/mL
Pharmacologic Class

Regulatory & Marketing

Labeler Name
Bipso Gmbh
Product Type
Human Prescription Drug
Marketing Category
UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE -
Start Marketing Date
07-01-2022
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 76381-930-06 identifies a specific commercial package of 6 bottle, glass in 1 box / 500 ml in 1 bottle, glass of Iomeron, a human prescription drug labeled by Bipso Gmbh. This injection, solution is formulated for intravascular use and contains iomeprol as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bipso Gmbh on July 01, 2022. The current certification is valid through December 31, 2026.

How is this Bipso Gmbh product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 76381093006. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
76381-930-06
11-Digit CMS (5-4-2)
76381-0930-06

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.